Correlation Between Protagonist Therapeutics and Emergent Biosolutions
Can any of the company-specific risk be diversified away by investing in both Protagonist Therapeutics and Emergent Biosolutions at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Protagonist Therapeutics and Emergent Biosolutions into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Protagonist Therapeutics and Emergent Biosolutions, you can compare the effects of market volatilities on Protagonist Therapeutics and Emergent Biosolutions and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Protagonist Therapeutics with a short position of Emergent Biosolutions. Check out your portfolio center. Please also check ongoing floating volatility patterns of Protagonist Therapeutics and Emergent Biosolutions.
Diversification Opportunities for Protagonist Therapeutics and Emergent Biosolutions
0.02 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Protagonist and Emergent is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Protagonist Therapeutics and Emergent Biosolutions in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Emergent Biosolutions and Protagonist Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Protagonist Therapeutics are associated (or correlated) with Emergent Biosolutions. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Emergent Biosolutions has no effect on the direction of Protagonist Therapeutics i.e., Protagonist Therapeutics and Emergent Biosolutions go up and down completely randomly.
Pair Corralation between Protagonist Therapeutics and Emergent Biosolutions
Given the investment horizon of 90 days Protagonist Therapeutics is expected to generate 0.56 times more return on investment than Emergent Biosolutions. However, Protagonist Therapeutics is 1.78 times less risky than Emergent Biosolutions. It trades about 0.08 of its potential returns per unit of risk. Emergent Biosolutions is currently generating about -0.57 per unit of risk. If you would invest 3,758 in Protagonist Therapeutics on December 6, 2024 and sell it today you would earn a total of 147.00 from holding Protagonist Therapeutics or generate 3.91% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Protagonist Therapeutics vs. Emergent Biosolutions
Performance |
| Timeline |
| Protagonist Therapeutics |
| Emergent Biosolutions |
Protagonist Therapeutics and Emergent Biosolutions Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Protagonist Therapeutics and Emergent Biosolutions
The main advantage of trading using opposite Protagonist Therapeutics and Emergent Biosolutions positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Protagonist Therapeutics position performs unexpectedly, Emergent Biosolutions can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Emergent Biosolutions will offset losses from the drop in Emergent Biosolutions' long position.| Protagonist Therapeutics vs. Revolution Medicines | Protagonist Therapeutics vs. Akero Therapeutics | Protagonist Therapeutics vs. Avidity Biosciences | Protagonist Therapeutics vs. Stoke Therapeutics |
| Emergent Biosolutions vs. Zoetis Inc | Emergent Biosolutions vs. Bausch Health Companies | Emergent Biosolutions vs. Neurocrine Biosciences | Emergent Biosolutions vs. Akanda Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |